Board of Directors
Officers
Jeffrey Newcorn, M.D. | President
Mt. Sinai Medical Center
1st Term: 2016 - 2019
President Elect: 2018 - 2020
President: 2020-2022
Biography
Ann Childress, M.D. | President Elect
PsychiatristCenter for Psychiatry and Behavioral Medicine, Inc.
1st Term: 2018 - 2021
President Elect: 2020-2022
Biography
Joseph Biederman, M.D. | Past President
Massachusetts General Hospital
1st Term: 2007 - 2015
President Elect: 2016 - 2018
President: 2018 - 2020
Past President: 2020-2022
Biography
Tanya Froehlich, M.D. | Treasurer
Cincinnati Children’s Hospital
1st Term: 2014 - 2018
2nd Term: 2018 - 2021
Treasurer: 2020-2022
Biography
David Goodman, M.D. | Secretary
Johns Hopkins School of Medicine
1st Term: 2016 - 2019
2nd Term: 2019 - 2022
Secretary 2020 - 2022
Biography
Board Members
Maria Acosta, M.D.*
NHGRI/NIH
1st Term: 2020-2023
Biography
*Dr. Acosta is serving in a personal capacity
Lenard Adler, M.D.
NYU School of Medicine
President: 2007 - 2011
Past President: 2012 - 2015
1st Term: 2016 - 2019
2nd Term: 2019 - 2022
Biography
Thomas Brown, Ph.D.
Keck School of Medicine of University of Southern California
1st Term: 2017 - 2020
2nd Term: 2020-2023
Biography
Greg Mattingly, M.D.
Washington University School of Medicine
1st Term: 2014 - 2018
2nd Term: 2019 - 2022
Biography
Martin Katzman, M.D., B.Sc., FRCP(C)
START Clinic for Mood and Anxiety Disorders
1st Term: 2021 - 2024
Biography
Beth Krone, Ph.D.
Clinical Research Coordinator-Post DocIcahn School of Medicine at Mount Sinai
1st Term: 2018 – 2021
2nd Term: 2021 – 2024
Biography
Keith McBurnett, Ph.D.
University of California, San Francisco
1st Term: 2017 - 2020
2nd Term: 2020-2023
Biography
Brooke Molina, Ph.D.
Professor of Psychiatry, Psychology, and PediatricsUniversity of Pittsburgh
1st Term: 2018 - 2021
1st Term: 2021 - 2024
Biography
Andrew Nierenberg, M.D.
Andrew Nierenberg, M.D.
1st Term: 2016 - 2019
2nd Term: 2019 - 2022
Biography
Joel Nigg, Ph.D.
Center for ADHD Research at Oregon Health & Science University
1st Term: 2020 - 2023
Biography
Douglas Russell, M.D.
University of Washington / Seattle Children's
1st Term: 2021 - 2024
Currently, Dr. Waite serves as a Board of Director for Corporate Trinity Health, which serves people in 21 states with 82 hospitals; 89 continuing care facilities, home health, and hospice programs. She is also on several editorial boards for nursing and interdisciplinary journals.
He has received many honors for his work, including named Fellow of the American Psychological Association (Division 12, 54); Diplomate in Clinical psychology (ABPP), and in 2017 received the lifetime achievement award from Children and Adults with Attention Deficit Hyperactivity Disorder (CHADD).
Dr. Stein has over 100 publications, including articles in Journal of the American Academy of Child and Adolescent Psychiatry, Journal of Child Psychiatry and Psychology, Pediatrics, Nature Medicine, and the New England Journal of Medicine. In 1999, he coedited the textbook, Attention Deficit and Hyperactivity in Children and Adults. Dr. Stein is an Associate Editor for Journal of Attention Disorders and Journal of Child and Adolescent Psychopharmacology.
Dr. Stein has received research support from the National Institute of Health, private foundations, and industry. He has done significant work on medical mimics of ADHD, such a sleep problems and thyroid disease, adaptive dysfunction, dose response and comparative efficacy of ADHD medications, and molecular genetics. Along with collaborators, Drs. Jeffrey Newborn, Andrea Chronis-Tuscano, Margaret Weiss, and Tanya Froehlich, current work is on treating ADHD in parents, pharmacogenomics, and sequencing and personalizing ADHD treatments throughout the lifespan.
Dr. Stein has been a board member of APSARD since it’s founding, past president (2016-2018), and currently chair of the APSARD advisory council.
Dr. Solanto’s research on the cognitive and behavioral functioning of children with ADHD, the effects of psychostimulants, and characteristics of the subtypes of ADHD has been supported by grants from the National Institute of Neurological Diseases, the
National Institute of Mental Health, and the National Institute of Child Health and Human Development. Dr. Solanto has also worked extensively with adults with ADHD. She developed a novel cognitive-behavioral intervention which targets problems of time-management and organization in adults with ADHD and which was the focus of an NIMH-sponsored treatment efficacy study, published in the American Journal of Psychiatry. The manual for therapists, titled Cognitive-Behavioral Treatment of Adult ADHD: Targeting Executive Dysfunction was published in 2011 (Guilford Press).
Dr. Solanto is active in clinical work with adults and children, and in the training of psychiatrists and psychologists to diagnose and treat AD/HD and related disorders. She has conducted workshops with parents concerning identification and treatment of children with AD/HD, and has presented to adult self-help organizations on strategies to improve organization and self-management. Dr. Solanto has published numerous scholarly papers concerning ADHD in children and adults and is a frequent reviewer for professional journals. She has served as a grant reviewer for NIMH. Currently, she is a member of the editorial boards of the Journal of Attention Disorders and The ADHD Report. She serves on the professional advisory boards of CHADD (Children and Adults with ADHD) and NCLD (National Center for Learning Disabilities). Dr. Solanto edited a volume (with Amy Arnsten and Xavier Castellanos) titled: Stimulant Drugs and ADHD: Basic and Clinical Neuroscience, (Oxford University Press), which is an investigation of the mechanisms of action of stimulants in ADHD.
He has been the recipient of the American Psychiatric Association Blanche Ittelson Award for Excellence in Child Psychiatric Research, the American Academy of Child and Adolescent Psychiatry Charlotte Norbert Rieger Award for Scientific Achievement. He has been inducted into the CHADD “Hall of Fame”. Dr Biederman has also been selected every year since its inception into the “The Best Doctors in America” compilation of the best physicians in the country.
Dr. Biederman has been a mentor to more than 15 junior investigators in the field. He is on the editorial board of multiple journals, a reviewer for most of the Psychiatric journals, and has served as a grant reviewer in the Child Psychopathology and Treatment Review Committee of the NIMH. Dr. Biederman is the author and co-author of close to 600 scientific articles, 650 scientific abstracts, and 70 book chapters.
In 2000, Dr. Biederman pioneered and established a Stanley Foundation Center at the Massachusetts General Hospital dedicated to the treatment of pediatric bipolar disorder. Dr. Biederman was the recipient of the 1998 NAMI Exemplary Psychiatrist award. He was also the recipient of the 2002 NARSAD Senior Investigator award. Since 2002 Dr. Biederman has been Associate Editor and from 2005-2006 Deputy Editor for Child Psychiatry in Biological Psychiatry, ranked as the third most impactful scientific journal in Psychiatry. In 2005 Dr. Biederman was appointed Chair of the section on ADHD at the World Psychiatric Association. He was also recently selected by the Massachusetts Psychiatric Society Awards committee as the recipient of the 2007 Outstanding Psychiatrist Award for Research. In 2007, Dr. Biederman received the Excellence in Research Award from the New England Council of Child and Adolescent Psychiatry. He was also awarded the Mentorship Award from the Department of Psychiatry at the Massachusetts General Hospital in September.
As of March 2007, Dr. Biederman has been ranked as the second highest producer of high-impact papers in psychiatry overall throughout the world with 235 papers cited a total of 7048 times over the past 10 years as determined by the Institute for Scientific Information (ISI). The same organization ranked Dr. Biederman at #1 in terms of total citations to his papers published on ADD/ADHD in the past decade. Dr. Biederman's work is supported by multiple federal and pharmaceutical industry grants.
Dr. Froehlich also enhances care for children with ADHD through teaching and other professional activities. She has served as an invited speaker providing seminars for professionals and workshops for families in international, national, and regional forums. Currently, she serves on the Executive Board for the American Professional Society of ADHD and Related Disorders, co-chairs the Society for Developmental and Behavioral Pediatrics ADHD Special Interest Group, and is an Editorial Board Member for the Journal of Developmental and Behavioral Pediatrics. In addition, Dr. Froehlich has a strong interest in interprofessional training and mentoring. She is site Principal Investigator for a state-funded grant whose mission is train professionals from a variety of disciplines to provide enhanced care for families on Ohio Medicaid, with a special emphasis on care of developmental and mental health conditions. Dr. Froehlich is also supervisor for a Leadership Education in Neurodevelopmental Disorders interdisciplinary trainee group whose project focuses on elucidating the needs of families in homeless shelters. In addition, Dr. Froehlich serves as Associate Director of the Developmental and Behavioral Pediatrics Fellowship as well as the Director of Research Training for the Cincinnati Children’s Hospital Division of Developmental and Behavioral Pediatrics, where she is Associate Professor of Pediatrics.
Dr. Froehlich is a graduate of Yale University School of Medicine. She completed her residency in pediatrics at the Children’s Hospital of Philadelphia, as well as a Developmental-Behavioral Pediatrics and a National Research Service Award fellowship at Cincinnati Children’s Hospital Medical Center.
*Dr. Acosta is serving in a personal capacity.
Kevin Antshel, PhD, is Professor of Psychology, Director of the Clinical Psychology doctoral program and Director of the ADHD Lifespan, Treatment Education and Research (ALTER) program at Syracuse University. He is also an Adjunct Associate Professor of Psychiatry at SUNY-Upstate Medical University in Syracuse, NY. Dr. Antshel is an active researcher and clinician and has specialized in ADHD for nearly 20 years. He has had the pleasure of training hundreds of doctoral students, residents in psychiatry, pediatrics and family medicine who have rotated through the ALTER clinic.
His research interests focus on understanding the heterogeneity of ADHD, especially ADHD in the context of medical disorders such as 22q11.2 deletion syndrome and phenylketonuria. Clinically, Dr. Antshel has focused on developing and testing innovative psychosocial treatments for adolescents and young adults with ADHD and associated conditions. More recently, Dr. Antshel has focused on issues related to college students with ADHD including how best to reduce stimulant misuse on college campuses.
Dr. Antshel has over 125 peer-reviewed publications, including papers in JAMA Psychiatry, Journal of the American Academy of Child and Adolescent Psychiatry, Journal of Child Psychology and Psychiatry, Psychological Medicine, Journal of Clinical Child & Adolescent Psychology and the American Journal of Psychiatry. He is on the editorial boards of the Journal of Attention Disorders, the ADHD Report and the Journal of Abnormal Child Psychology. In 2014, he co-edited an issue of Child and Adolescent Psychiatric Clinics of North America with Stephen Faraone, Ph.D. Dr. Antshel has served previously on the Scientific Program Committees for APSARD and the World Congress on ADHD. He regularly serves as a grant reviewer on NIH and international review committees.
Dr. Antshel is interested in joining the APSARD Board of Directors to both give back to APSARD as well as participate in strategic planning for the future.
Dr. Behrens is a workflow/efficiency minded and "technologically psychiatrist" (for whatever that may mean) with clinical interest Adult ADHD and the use of technology to improve and expand the patient physician. Throughout his time in residency and as faculty, his clinical interests and specialization drifted to the evaluation and treatment of ADHD in adults where he often worked with high functioning professionals in various time/travel intensive work roles. He soon came to realize the logistical difficulties that such patients face in terms of maintaining treatment and began envisioning ways to utilize technology to more conveniently meet patient/physician needs. While advising and networking with various healthcare startups, he learned the merits of lean-model processing and later,
During his "mid-thirties crisis," made the difficult decision to leave academic medicine to pursue the start-up of a specialized adult adhd practice where he could more readily adapt and evolve with technology and workflows to both meet unique patient needs as well as the personal need to be "ever searching, ever building, ever growing."
Following graduation, he remained as an assistant clinical professor working in an outpatient setting and teaching UW medical students and residents. In 2016, he moved from Madison, WI to Milwaukee, WI to pursue the startup of Envision ADHD serving as CEO and medical director. He is a co-founder of HealthtechMKE in Milwaukee, WI and is a champion of the physician voice in the health technology space. He is currently serving on the American Psychiatric Association (APA) Healthcare Quality Council and on the board of the American Professional Society of ADHD and related disorders (APSARD). He is past chair of the American Medical Association's Young Physician Section Innovation Committee and past president of the Dane County Medical Society.
Mark Bertin, MD is a board certified developmental behavioral pediatrician. He attended UCLA Medical School, completing residency at Oakland Children's Hospital and fellowship in developmental pediatrics at the Albert Einstein College of Medicine. Dr. Bertin is an assistant professor pediatrics at New York Medical College, on faculty for the Windward Teacher Training Institute and the Common Sense Media editorial advisory board, and leads mindfulness classes for parents. Dr. Bertin's book “The Family ADHD Solution” integrates mindfulness into ADHD care, and his blog is available on both Huffington Post and Psychology Today.
Dr. Thomas E. Brown is a clinical psychologist who earned his Ph.D. at Yale University. He is Director of the Brown Clinic for Attention and Related Disorders in Manhattan Beach, California. After 20 years of serving on the clinical faculty of Yale Medical School, he has now joined the clinical faculty of the Dept. of Psychiatry & Behavioral Sciences at the Keck Medical School of the University of Southern California as a clinical associate professor. In May, 2017 he relocated his clinic from CT to Manhattan Beach, CA. Dr. Brown is author of Smart but Stuck: Emotions in Teens and Adults with ADHD (Jossey-Bass/Wiley, 2014), A New Understanding of ADHD in Children & Adults: Executive Function Impairments (Routledge, 2013) and the prize-winning Attention Deficit Disorder: The Unfocused Mind in Children and Adults.(Yale Press, 2005). He edited ADHD Comorbidities: Handbook for ADHD Complications in Children and Adults (American Psychiatric Press, 2009) and is author of the Brown ADD Scales (Pearson). His most recent book is Outside the Box: Rethinking ADD/ADHD in Children and Adults--A Practical Guide (American Psychiatric Publishing, 2017). He has presented symposia and workshops throughout the US and in more than 40 other countries. His website is: www.BrownADHDclinic.com
Dr. Dixon is licensed clinical psychologist and Clinical Professor in the Department of Psychiatry and Behavioral Sciences. She has a long history of work in child psychopathology, specifically the areas of depression, anxiety, PTSD, ADHD and learning differences in children. Currently, Dr. Dixon is the director of clinical management and community outreach for the AIR (Attention, Impulsivity & Regulation) Lab. She is responsible the the clinical and diagnostic fidelity of the AIR Lab research. She also has spent many years educating and training psychology graduate students, interns, and post-doctoral fellows as well as medical students, residents and child psychiatry fellows.
Sam Goldstein, Ph.D. is an Adjust Assistant Professor at the university of Utah School of Medicine and on staff at the University Neuropsychiatric Institute. He is Clinical Director of the Neurology Learning and Behavior Center. The Center conducts evaluation, consultation and provides treatment services to 300 individuals and families each year. Dr. Goldstein has authored fifty trade and science texts as well as over three dozen science based book chapters and thirty peer reviewed research articles. He has also co-authored six psychological tests. He currently serves as Editor in Chief of the Journal of Attention Disorders and sits on the editorial boards of six peer reviewed journals. He is Co-editor of the Encyclopedia of Child Development. Recent books include the Handbook of Intelligence: Evolutionary Theory, Historical Perspective and Current Concepts, Handbook of Resilience - 2nd Edition, Raising Resilient Children with Autism Spectrum Disorders, Handbooks of Neurodevelopmental and Genetic Disorders in Children and Adults, Assessment of Intelligence and Achievement, Assessment of Autism Spectrum Disorders, Handbook of Executive Functioning, Assessment of Impairment and Managing Children's Classroom Behavior: Creating Sustainable Resilient Classrooms. He is the co-author of the Autism Spectrum Rating Scales, Comprehensive Executive Functioning Inventory, Rating Scales of Impairment and the Cognitive Assessment System Second Edition. Currently, he has three books and four psychological tests in development. He has lecture to thousands of professionals and the lay public in the U.S., South America, Asia, Australia, and Europe.
Frances Rudnick Levin, MD is the Kennedy-Leavy Professor of Psychiatry at Columbia University and the Chief of the Division on Substance Use Disorders at NYSPI/Columbia University. For the past 20 years, she has been the Director of the Addiction Psychiatry Fellowship Program at New York Presbyterian Hospital and for the past 14 years, she has been the PI of a T32 NIDA funded Substance Abuse Research Fellowship. Dr. Levin graduated from Cornell University Medical College and completed her psychiatric residency at the New York Hospital-Payne Whitney Clinic. She is Medical Director of the Providers’ Clinical Support System- Medication Assisted Treatments (PCSS-MAT), a SAMHSA-supported national training and mentoring initiative focused on addressing the opioid use disorder crisis. Also, she is the Medical Director of a SAMHSA-supported State Targeted Response technical assistance grant to states that received funding to address the national opioid epidemic.
She is the principal investigator on several federally funded grants, including a U54 Medications Development grant evaluating novel treatments for opiate and cannabis use disorders, a K24 Mid-Career Investigator Award and collaborates on several other grants. Her current research interests include pharmacologic and psychotherapeutic treatment interventions for cocaine and marijuana use disorder, and treatment approaches for adults with substance use disorders and attention-deficit hyperactivity disorder along with other psychiatric illnesses. Dr. Levin has over 200 articles and book chapters on a wide range of topics including treatments of substance use disorders, assessment and treatment of co-occurring psychiatric illnesses and vulnerabilities associated with substance use disorders. She has served on several advisory panels and ad-hoc federal grant review groups and was as a member of the NIDA – Initial Review Group: Training and Career Development Subcommittee for 8 years and served as a member to the NIDA Interventions to Prevent and Treat Addiction (IPTA). She is an editorial board member of three journals, past President of the American Academy of Addiction Psychiatry and past Chair of the APA Council on Addiction Psychiatry.
Dr. Mattingly graduated Summa Cum Laude in chemical engineering before pursuing his medical degree at Washington University where he received a Fullbright Scholarship. He then completed his psychiatry residency at Washington University and is a diplomate of the American Board of Psychiatry and Neurology. He is board certified in psychiatry with a subspecialty in adolescent psychiatry. Dr. Mattingly has received numerous awards and distinctions including the Academy of Child and Adolescent Psychiatry National Leadership Award, the Upjohn Neuropsychiatry Research Award, and the Southern Psychiatric Association
Research Award.
As a principal investigator in over 300 clinical trials, he has been an invited presenter at numerous national and international medical conferences. Having served as a certified examiner for both the NFL and MLB, Dr. Mattingly also sits on the board of directors for Headway House; a “club house” program for individuals with developmental disabilities and chronic mental health conditions in St Louis. Dr. Mattingly’s work has been published in The Journal of Neuropsychiatry and Clinical Neurosciences, The Journal of Clinical Psychiatry, The Journal of Child and Adolescent Psychiatry, Current Psychiatry, CNS
Spectrums and Postgraduate Medicine.
Dr. Mattingly has dedicated the past 25 years of his career to caring for children, adolescents and adults with ADHD and associated conditions. His work on medical education in ADHD received the “Best Poster Award” at this year’s ADHD World Congress in Vancouver. Most importantly, as a parent of a child with developmental disabilities, Dr. Mattingly understands the ongoing need for improved coordination of research, education and clinical care for our patients and their families.